Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pathologic Processes × Trastuzumab × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 43 Stomach Neoplasms 10 Esophageal Neoplasms 6 Neoplasms 5 Neoplasm Metastasis 5 Colorectal Neoplasms 4 Adenocarcinoma Of Esophagus 4 Colonic Neoplasms 3 Brain Neoplasms 3 Triple Negative Breast Neoplasms 2 Solid Tumors 2 Rectal Neoplasms 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Inflammatory Breast Neoplasms 2 HER2-positive Gastric Cancer 2 HER2-positive Early Breast Cancer 2 HER2-positive Breast Cancer 2 Carcinoma, Non-Small-Cell Lung 2 Anatomic Stage I Breast Cancer AJCC v8 2 Adenocarcinoma 2 Solid Cancer 1 Salivary Gland Neoplasms 1 Resectable HER2-positive Breast Cancer 1 Prostatic Neoplasms 1 Patient Preference 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Meningeal Neoplasms 1

Interventions

pembrolizumab 1 Pemetrexed 1 MRX-2843 1 Control Groups 1 Cisplatin 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡